Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 25

CN22 - Survivorship care in melanoma cancer survivors

Date

21 Oct 2023

Session

Poster session 25

Topics

Immunotherapy;  Survivorship

Tumour Site

Melanoma

Presenters

Riley Fadden

Citation

Annals of Oncology (2023) 34 (suppl_2): S1229-S1256. 10.1016/annonc/annonc1321

Authors

R. Fadden1, A. Sorrentino2

Author affiliations

  • 1 Ambulatory Oncology Dept., Massachusetts General Hospital Cancer Center, Harvard Medical School, 02114 - Boston/US
  • 2 Oncology - Melanoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, 02114 - Boston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN22

Background

Survivorship care provides numerous benefits for oncology survivors; however, resources and programing are not routinely implemented in clinical practice. The increasing population of cancer survivors presents the need for improvement in patient centered continuity of care. The Melanoma Survivorship Program aims to improve the experience and outcomes for melanoma survivors who have completed treatment. The goal is to aid patients' transition from the acute phase of treatment to living with a chronic condition while maintaining or improving quality of life.

Methods

Patients submit a survey to evaluate the long term emotional, physical, and financial effects of cancer and cancer therapy. They then meet with a Nurse Practitioner (NP) and a Social Worker to formulate an individual care plan. The survivorship program utilizes referrals to an interdisciplinary care team including cardiovascular health, exercise, nutrition, sexual health and intimacy, psychosocial care, and financial support. Additionally, they provide connection with patients’ primary care provider for continuity of care.

Results

This poster provides a recommendation for NPs to promote survivorship referrals in clinical practice. Data was produced through analysis and reporting on the effectiveness of survivorship programs in randomized control trials as part of a systematic review. Protocols providing access to comprehensive survivorship care in previous studies were examined and used to measure the effectiveness of survivorship programs in addressing patient quality of life. Findings support the recommendation of survivorship programs and interventions, specifically those studies which utilized and adapted the National Comprehensive Cancer Network Survivorship Assessment and the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.

Conclusions

All forms of interventions were equally beneficial and largely dependent on patient goals. Therefore, NPs should encourage patients to engage in aspects of survivorship care that reflect their priorities. Additional research is needed to assess if survivorship care as described in this poster is effective at improving quality of life among melanoma cancer survivors long term.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.